Sera Prognostics is developing a biomarker test for predicting very preterm birth.
- Can Connected Wearable Medical Devices Improve Healthcare?
- Guardant Hits Milestone with FDA Nod for Liquid Biopsy Test
- Siemens Healthineers Changes Antibody Testing Conversation with New EUA
- Another COVID-19 Antibody Test Bites the Dust
- Complying with ISO 14971:2019
- Strategies to Prevent Component Shortages During a Crisis